BlueAllele Corporation v. Intellia Therapeutics, Inc.
1:24-cv-00791
Overview
Parties
Defendant
Intellia Therapeutics, Inc. Operating Company
Represented By
16 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
BlueAllele Corporation NPE (Individual / Inventor)
Represented By
18 Attorneys ListedFish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 12 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11091756
Methods for targeted insertion of dna in genes
|
Filed: 2020-02-25
Issued: 2021-08-17
|
Active (13.3 yrs remaining)
Expires: 2040-02-25
|
|
|
US11254930
Methods for targeted insertion of DNA in genes
|
Filed: 2021-07-02
Issued: 2022-02-22
|
Active (12.9 yrs remaining)
Expires: 2039-10-14
|
|
|
US11365407
Methods for targeted insertion of DNA in genes
|
Filed: 2022-02-01
Issued: 2022-06-21
|
Active (15.2 yrs remaining)
Expires: 2042-02-01
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
3
Dispositive
1
Granted
0
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings